EP4216914A1 - Spray de soins à deux phases pour les cheveux - Google Patents
Spray de soins à deux phases pour les cheveuxInfo
- Publication number
- EP4216914A1 EP4216914A1 EP21772738.7A EP21772738A EP4216914A1 EP 4216914 A1 EP4216914 A1 EP 4216914A1 EP 21772738 A EP21772738 A EP 21772738A EP 4216914 A1 EP4216914 A1 EP 4216914A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- hair treatment
- hair
- weight
- treatment composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007921 spray Substances 0.000 title description 4
- 239000000203 mixture Substances 0.000 claims abstract description 91
- 150000004651 carbonic acid esters Chemical class 0.000 claims abstract description 9
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 8
- 230000003766 combability Effects 0.000 claims abstract description 7
- 230000003752 improving hair Effects 0.000 claims abstract description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 47
- 239000003921 oil Substances 0.000 claims description 47
- 235000019198 oils Nutrition 0.000 claims description 47
- 150000002148 esters Chemical class 0.000 claims description 44
- 239000003531 protein hydrolysate Substances 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 claims description 17
- 229940088594 vitamin Drugs 0.000 claims description 15
- 229930003231 vitamin Natural products 0.000 claims description 15
- 235000013343 vitamin Nutrition 0.000 claims description 15
- 239000011782 vitamin Substances 0.000 claims description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 239000004480 active ingredient Substances 0.000 claims description 12
- 229920001296 polysiloxane Polymers 0.000 claims description 12
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 12
- 229920006317 cationic polymer Polymers 0.000 claims description 10
- 239000002480 mineral oil Substances 0.000 claims description 10
- 150000001413 amino acids Chemical class 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 8
- 239000008158 vegetable oil Substances 0.000 claims description 7
- 239000003093 cationic surfactant Substances 0.000 claims description 6
- 230000003750 conditioning effect Effects 0.000 claims description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 206010019049 Hair texture abnormal Diseases 0.000 claims description 4
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N 1-Tetradecanol Natural products CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 claims description 3
- MCLMZMISZCYBBG-UHFFFAOYSA-N 3-ethylheptanoic acid Chemical compound CCCCC(CC)CC(O)=O MCLMZMISZCYBBG-UHFFFAOYSA-N 0.000 claims description 3
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 claims description 3
- 150000004650 carbonic acid diesters Chemical class 0.000 claims description 3
- 229960000541 cetyl alcohol Drugs 0.000 claims description 3
- RLGQACBPNDBWTB-UHFFFAOYSA-N cetyltrimethylammonium ion Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)C RLGQACBPNDBWTB-UHFFFAOYSA-N 0.000 claims description 3
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 3
- 229940043348 myristyl alcohol Drugs 0.000 claims description 3
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N n-hexadecyl alcohol Natural products CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 3
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims description 3
- 229940086539 peg-7 glyceryl cocoate Drugs 0.000 claims description 3
- 229940070718 behentrimonium Drugs 0.000 claims description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 2
- 229960003431 cetrimonium Drugs 0.000 claims description 2
- UQAZQVWPGFLIBN-UHFFFAOYSA-N CCCCCCCCCCCCCCCCOC(C(CCCC)OCC)=O Chemical compound CCCCCCCCCCCCCCCCOC(C(CCCC)OCC)=O UQAZQVWPGFLIBN-UHFFFAOYSA-N 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 239000012071 phase Substances 0.000 abstract description 93
- 150000005690 diesters Chemical class 0.000 abstract description 3
- 239000008346 aqueous phase Substances 0.000 abstract description 2
- 239000002932 luster Substances 0.000 abstract 1
- 229940060184 oil ingredients Drugs 0.000 description 41
- -1 Quaternium-18 Chemical compound 0.000 description 32
- 239000000047 product Substances 0.000 description 27
- 235000018102 proteins Nutrition 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 102000008186 Collagen Human genes 0.000 description 10
- 108010035532 Collagen Proteins 0.000 description 10
- 241000209140 Triticum Species 0.000 description 10
- 235000021307 Triticum Nutrition 0.000 description 10
- 229920001436 collagen Polymers 0.000 description 10
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 9
- 108010076876 Keratins Proteins 0.000 description 9
- 102000011782 Keratins Human genes 0.000 description 9
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 9
- 229940024606 amino acid Drugs 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 108010073771 Soybean Proteins Proteins 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 7
- 210000004761 scalp Anatomy 0.000 description 7
- 229940001941 soy protein Drugs 0.000 description 7
- 150000003722 vitamin derivatives Chemical class 0.000 description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 6
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 6
- 235000020957 pantothenol Nutrition 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 125000002091 cationic group Chemical group 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 229940101267 panthenol Drugs 0.000 description 5
- 239000011619 pantothenol Substances 0.000 description 5
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 239000005018 casein Substances 0.000 description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 4
- 235000021240 caseins Nutrition 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 235000005152 nicotinamide Nutrition 0.000 description 4
- 239000011570 nicotinamide Substances 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 3
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 3
- 240000000950 Hippophae rhamnoides Species 0.000 description 3
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 3
- 102000014171 Milk Proteins Human genes 0.000 description 3
- 108010011756 Milk Proteins Proteins 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- 229930003756 Vitamin B7 Natural products 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 150000002191 fatty alcohols Chemical class 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 3
- 235000021239 milk protein Nutrition 0.000 description 3
- 229960003966 nicotinamide Drugs 0.000 description 3
- SERHXTVXHNVDKA-UHFFFAOYSA-N pantolactone Chemical compound CC1(C)COC(=O)C1O SERHXTVXHNVDKA-UHFFFAOYSA-N 0.000 description 3
- 229940115458 pantolactone Drugs 0.000 description 3
- SIEVQTNTRMBCHO-UHFFFAOYSA-N pantolactone Natural products CC1(C)OC(=O)CC1O SIEVQTNTRMBCHO-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000029219 regulation of pH Effects 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- 235000011912 vitamin B7 Nutrition 0.000 description 3
- 239000011735 vitamin B7 Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 229930182843 D-Lactic acid Natural products 0.000 description 2
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 2
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 2
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 2
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 2
- 240000000912 Macadamia tetraphylla Species 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920000688 Poly[(2-ethyldimethylammonioethyl methacrylate ethyl sulfate)-co-(1-vinylpyrrolidone)] Polymers 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- XWCYDHJOKKGVHC-UHFFFAOYSA-N Vitamin A2 Chemical compound OCC=C(C)C=CC=C(C)C=CC1=C(C)C=CCC1(C)C XWCYDHJOKKGVHC-UHFFFAOYSA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 125000005210 alkyl ammonium group Chemical group 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000021302 avocado oil Nutrition 0.000 description 2
- 239000008163 avocado oil Substances 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N beta-Carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 230000003695 hair diameter Effects 0.000 description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000005528 methosulfate group Chemical class 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 150000003009 phosphonic acids Chemical class 0.000 description 2
- 229920002553 poly(2-methacrylolyloxyethyltrimethylammonium chloride) polymer Polymers 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 235000019149 tocopherols Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 239000002888 zwitterionic surfactant Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- MJGBOFOZSAEULI-RUCXOUQFSA-N (2s)-5-oxopyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCC(=O)N1.OC(=O)[C@@H]1CCC(=O)N1 MJGBOFOZSAEULI-RUCXOUQFSA-N 0.000 description 1
- NRTKYSGFUISGRQ-UHFFFAOYSA-N (3-heptanoyloxy-2,2-dimethylpropyl) heptanoate Chemical compound CCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCC NRTKYSGFUISGRQ-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 125000006702 (C1-C18) alkyl group Chemical group 0.000 description 1
- 125000006686 (C1-C24) alkyl group Chemical group 0.000 description 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 1
- OWEGWHBOCFMBLP-UHFFFAOYSA-N 1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one Chemical compound C1=CN=CN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 OWEGWHBOCFMBLP-UHFFFAOYSA-N 0.000 description 1
- HANWHVWXFQSQGJ-UHFFFAOYSA-N 1-tetradecoxytetradecane Chemical compound CCCCCCCCCCCCCCOCCCCCCCCCCCCCC HANWHVWXFQSQGJ-UHFFFAOYSA-N 0.000 description 1
- OYINQIKIQCNQOX-UHFFFAOYSA-M 2-hydroxybutyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCC(O)C[N+](C)(C)C OYINQIKIQCNQOX-UHFFFAOYSA-M 0.000 description 1
- FVEWVVDBRQZLSJ-QTWKXRMISA-N 2-hydroxyethyl-dimethyl-[3-[[(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoyl]amino]propyl]azanium;chloride Chemical compound [Cl-].OCC[N+](C)(C)CCCNC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FVEWVVDBRQZLSJ-QTWKXRMISA-N 0.000 description 1
- TWNJSZBYPPKSFE-BAYNMDCWSA-M 2-hydroxypropyl-[2-[2-hydroxypropyl-[2-[(e)-octadec-9-enoyl]oxypropyl]amino]ethyl]-methyl-[2-[(e)-octadec-10-enoyl]oxypropyl]azanium;methyl sulfate Chemical compound COS([O-])(=O)=O.CCCCCCCC\C=C\CCCCCCCC(=O)OC(C)CN(CC(C)O)CC[N+](C)(CC(C)O)CC(C)OC(=O)CCCCCCCC\C=C\CCCCCCC TWNJSZBYPPKSFE-BAYNMDCWSA-M 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XUHLIQGRKRUKPH-ITZCMCNPSA-N 3-(Allylsulphinyl)-L-alanine Chemical compound OC(=O)[C@@H](N)CS(=O)CC=C XUHLIQGRKRUKPH-ITZCMCNPSA-N 0.000 description 1
- IFYVAPPYWOMVDP-UHFFFAOYSA-N 3-[(2,4-diacetyloxy-3,3-dimethylbutanoyl)amino]propyl acetate Chemical compound CC(=O)OCCCNC(=O)C(OC(C)=O)C(C)(C)COC(C)=O IFYVAPPYWOMVDP-UHFFFAOYSA-N 0.000 description 1
- UWRBFYBQPCJRRL-UHFFFAOYSA-N 3-[bis(carboxymethyl)amino]propanoic acid Chemical compound OC(=O)CCN(CC(O)=O)CC(O)=O UWRBFYBQPCJRRL-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical class NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- ASOLQNQTXIEOPJ-YIQDKWKASA-N COS([O-])(=O)=O.CCCCCCCC\C=C/CCCCCCCC(=O)NCC[N+]1(C)CCN=C1CCCCCCC\C=C/CCCCCCCC Chemical compound COS([O-])(=O)=O.CCCCCCCC\C=C/CCCCCCCC(=O)NCC[N+]1(C)CCN=C1CCCCCCC\C=C/CCCCCCCC ASOLQNQTXIEOPJ-YIQDKWKASA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 235000016401 Camelina Nutrition 0.000 description 1
- 244000197813 Camelina sativa Species 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000019500 Grapefruit seed oil Nutrition 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- FFFHZYDWPBMWHY-UHFFFAOYSA-N L-Homocysteine Natural products OC(=O)C(N)CCS FFFHZYDWPBMWHY-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 239000004158 L-cystine Substances 0.000 description 1
- 235000019393 L-cystine Nutrition 0.000 description 1
- DATAGRPVKZEWHA-UHFFFAOYSA-N L-gamma-glutamyl-n-ethylamine Natural products CCNC(=O)CCC(N)C(O)=O DATAGRPVKZEWHA-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- JDHILDINMRGULE-LURJTMIESA-N N(pros)-methyl-L-histidine Chemical compound CN1C=NC=C1C[C@H](N)C(O)=O JDHILDINMRGULE-LURJTMIESA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 241000282372 Panthera onca Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 229920000691 Poly[bis(2-chloroethyl) ether-alt-1,3-bis[3-(dimethylamino)propyl]urea] Polymers 0.000 description 1
- 229920000289 Polyquaternium Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 241000221037 Pyrularia pubera Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N Retinaldehyde Chemical compound O=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- 235000001537 Ribes X gardonianum Nutrition 0.000 description 1
- 235000001535 Ribes X utile Nutrition 0.000 description 1
- 235000016919 Ribes petraeum Nutrition 0.000 description 1
- 244000281247 Ribes rubrum Species 0.000 description 1
- 235000002355 Ribes spicatum Nutrition 0.000 description 1
- 241000109365 Rosa arkansana Species 0.000 description 1
- 235000005066 Rosa arkansana Nutrition 0.000 description 1
- XUHLIQGRKRUKPH-UHFFFAOYSA-N S-allyl-L-cysteine sulfoxide Natural products OC(=O)C(N)CS(=O)CC=C XUHLIQGRKRUKPH-UHFFFAOYSA-N 0.000 description 1
- YDBYJHTYSHBBAU-YFKPBYRVSA-N S-methyl-L-methioninate Chemical compound C[S+](C)CC[C@H](N)C([O-])=O YDBYJHTYSHBBAU-YFKPBYRVSA-N 0.000 description 1
- 240000003935 Sclerocarya birrea Species 0.000 description 1
- 235000001836 Sclerocarya caffra Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 239000004904 UV filter Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000005396 acrylic acid ester group Chemical group 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- XUHLIQGRKRUKPH-DYEAUMGKSA-N alliin Chemical compound OC(=O)[C@@H](N)C[S@@](=O)CC=C XUHLIQGRKRUKPH-DYEAUMGKSA-N 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 239000010478 argan oil Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000010480 babassu oil Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000021324 borage oil Nutrition 0.000 description 1
- 239000010474 borage seed oil Substances 0.000 description 1
- 150000003842 bromide salts Chemical class 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229960003344 climbazole Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 108010006161 conchiolin Proteins 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 229940022769 d- lactic acid Drugs 0.000 description 1
- SCXCDVTWABNWLW-UHFFFAOYSA-M decyl-dimethyl-octylazanium;chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCC SCXCDVTWABNWLW-UHFFFAOYSA-M 0.000 description 1
- 229950006137 dexfosfoserine Drugs 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- UCYFZDNMZYZSPN-UHFFFAOYSA-N docosyl(trimethyl)azanium Chemical class CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C UCYFZDNMZYZSPN-UHFFFAOYSA-N 0.000 description 1
- CDIPRYKTRRRSEM-UHFFFAOYSA-M docosyl(trimethyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C CDIPRYKTRRRSEM-UHFFFAOYSA-M 0.000 description 1
- QIVLQXGSQSFTIF-UHFFFAOYSA-M docosyl(trimethyl)azanium;methyl sulfate Chemical compound COS([O-])(=O)=O.CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C QIVLQXGSQSFTIF-UHFFFAOYSA-M 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- IHDIFQKZWSOIBB-UHFFFAOYSA-M dodecyl-[(4-ethylphenyl)methyl]-dimethylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=C(CC)C=C1 IHDIFQKZWSOIBB-UHFFFAOYSA-M 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000007046 ethoxylation reaction Methods 0.000 description 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- 239000010460 hemp oil Substances 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- OEWKLERKHURFTB-UHFFFAOYSA-M hexadecyl(trimethyl)azanium;methyl sulfate Chemical compound COS([O-])(=O)=O.CCCCCCCCCCCCCCCC[N+](C)(C)C OEWKLERKHURFTB-UHFFFAOYSA-M 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 1
- 229940091173 hydantoin Drugs 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 229960005173 methiosulfonium chloride Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N n-hexadecanoic acid Natural products CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 238000004848 nephelometry Methods 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 1
- 229940081510 piroctone olamine Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000001944 prunus armeniaca kernel oil Substances 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 229940089970 quaternium-14 Drugs 0.000 description 1
- UKHVLWKBNNSRRR-TYYBGVCCSA-M quaternium-15 Chemical compound [Cl-].C1N(C2)CN3CN2C[N+]1(C/C=C/Cl)C3 UKHVLWKBNNSRRR-TYYBGVCCSA-M 0.000 description 1
- 229940096792 quaternium-15 Drugs 0.000 description 1
- 229940032044 quaternium-18 Drugs 0.000 description 1
- 229940097319 quaternium-22 Drugs 0.000 description 1
- 229940117359 quaternium-24 Drugs 0.000 description 1
- 229940079053 quaternium-27 Drugs 0.000 description 1
- 229940073745 quaternium-82 Drugs 0.000 description 1
- 235000020945 retinal Nutrition 0.000 description 1
- 239000011604 retinal Substances 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical compound NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- FAGMGMRSURYROS-UHFFFAOYSA-M trihexadecyl(methyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(CCCCCCCCCCCCCCCC)CCCCCCCCCCCCCCCC FAGMGMRSURYROS-UHFFFAOYSA-M 0.000 description 1
- CFSCETSZQVECLC-UHFFFAOYSA-M trimethyl(1-phenyltridecyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCC([N+](C)(C)C)C1=CC=CC=C1 CFSCETSZQVECLC-UHFFFAOYSA-M 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/03—Liquid compositions with two or more distinct layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
Definitions
- the application describes hair treatment agents in the form of a two-phase system with an oil and a water phase in the form of two separate, optically recognizable continuous phases with a common horizontal phase boundary, which contain a specific mixture of at least two different esters in the oil phase.
- the application also describes a method for hair conditioning using the hair treatment agent and the use of the hair treatment agent to improve specific care properties of hair.
- Two-phase hair conditioners have been known from the prior art for a long time and are highly valued by consumers because of their attractive appearance and ease of use.
- leave-on products which are applied to the hair (preferably sprayed) and care for it, preferably immediately after the two phases have been mixed for a short time.
- WO 2010/069995 describes two-phase products with a high polyol content in the water phase, which contain at least 5% by weight of a non-silicone oil (e.g. paraffins and/or isoparaffins) in the oil phase.
- a non-silicone oil e.g. paraffins and/or isoparaffins
- WO 2020/126219 describes silicone-free two-phase hair treatment agents which contain isoparaffins and at least two different esters.
- the present application was therefore based on the object of providing essentially silicone and mineral oil-free hair treatment agents in the form of two-phase systems with high care performance, which ensure an optimal balance between long-lasting and lasting care and good (scalp) compatibility.
- the hair treatment agents should have the highest possible water content while maintaining the same care performance and, in particular, should give previously damaged and/or dry and/or split hair more shine, suppleness, a soft, silky feel and improved detangleability and combability.
- a further aim was to make available two-phase hair treatment compositions which, even after regular use, do not weigh down the hair and which make the hair shinier and easier to shape and style.
- the hair treatment agents according to the invention have a demonstrable conditioning advantage on hair treated therewith.
- the combability, the shine of the hair and the feel of the hair, in particular previously stressed and/or damaged hair could be significantly improved using the agents according to the invention. They therefore have at least equivalent care properties to conventional two-phase hair care products comprising silicones and/or mineral oils.
- Hair treated with agents according to the invention has an overall healthier visual appearance.
- a first subject of the invention is a hair treatment agent in the form of a two-phase system with two separate, optically recognizable continuous phases with a common horizontal phase boundary, containing a water phase (I) and an oil phase (II), characterized in that the oil phase (II) - based on their total weight - a mixture of a) 5 to 25% by weight of at least one mono- and/or diester of a branched C4-C12 carboxylic acid and a linear or branched, saturated or unsaturated C4-C24 mono- or dialcohol, and b ) 65 to 90% by weight of at least one carbonic acid ester.
- the hair treatment compositions according to the invention comprise two optically separate phases which can be homogenized by shaking and which, when at rest, separate again into two separate, optically recognizable continuous phases with a common horizontal phase boundary.
- the emulsion produced by shaking is optimally stable for up to five, preferably up to three, more preferably up to two and most preferably up to one hour before separating back into the original two phases with a horizontal phase boundary.
- water phase (I) and the oil phase (II) have lower viscosity values.
- “lower viscosity values” are preferably to be understood as meaning viscosity values of the water phase (I) and the oil phase (II) of up to a maximum of 1000 mPas, more preferably 600 mPas and in particular 400 mPas (measured at 20° C. with a Brookfield viscometer DV-II, spindle 2 at 20 rpm).
- phases (I) or (II) are transparent.
- At least one of the two phases (I) and (II) is particularly preferably transparent.
- “transparency” means that the water phase (I) and/or the oil phase (II) at rest preferably has an NTU value (nephelometry turbidity unit) of at most 100, preferably at most 75, more preferably by has a maximum of 50 and in particular a maximum of 25 (measured, for example, with a turbidimeter of the Turbiquant® type from Merck).
- NTU value nephelometry turbidity unit
- the water phase (I) is transparent to slightly cloudy and the oil phase (II) of the care phase is milky-creamy.
- one of the two phases (I) or (II), preferably the water phase (I), can be colored with a cosmetically acceptable dye.
- the hair treatment compositions according to the invention can be sprayed.
- the hair treatment compositions according to the invention are suitable for application from a pump dispenser.
- An advantage of such an application form is the simple, clean and time-saving handling, because the hair treatment agents can be distributed from a suitable pump dispenser by simply actuating a pump valve as a fine spray and reach all areas of the hair.
- the ready-to-use (i.e. homogenized by shaking) hair treatment compositions according to the invention preferably have a viscosity of not more than 1000 mPas, preferably not more than 800 mPas, more preferably not more than 600 mPas and in particular not more than 500 mPas (each measured at 20 ° C with a Brookfield viscometer DV-II, spindle 2 at 20 rpm). Also preferred for such an application form is that according to the invention
- Hair conditioners are propellant-free.
- the hair treatment compositions according to the invention contain a) the aqueous phase (I) in a proportion by weight of at least 80% by weight, preferably at least 85% by weight and in particular at least 88% by weight, based on the total weight of the hair treatment composition and b) the oil phase (II) in a proportion by weight of at most 20% by weight, preferably at most 15% by weight and in particular at most 12% by weight, based on the total weight of the hair treatment composition.
- the water phase (I) based on its total weight—comprises at least 85% by weight, preferably at least 90% by weight and in particular at least 95% by weight, of water.
- the oil phase (II) contains a) 5 to 25% by weight of at least one mono- and/or diester of a branched C4-C12 carboxylic acid and a linear or branched, saturated or unsaturated C4-C24 mono- or dialcohol, and b ) 65 to 90% by weight of at least one carbonic acid ester.
- agents according to the invention which predominantly contain the oils a) and b) have excellent hair care performance and long-term stability.
- the oil phase (II) - based on its total weight - contains at least 75% by weight, preferably at least 77.5% by weight and in particular at least 80% by weight of the oils a) and b) contains.
- Hair treatment agents according to the invention are also advantageous in which the weight ratio of the esters a):b) is in the range from 1:3 to 1:20, preferably from 1:5 to 1:15 and in particular from 1:6 to 1:12.
- the hair care performance can thus be tailored to the individual hair type.
- Suitable esters a) must mix well with esters b) and, as a mixture, have good spreadability and effectiveness on the hair without weighing the hair down.
- Esters a) which do not leave an oily feeling or an oily film on the hair and/or the scalp are advantageous.
- Preferred esters a) can be selected from compounds of the formula (I) CH 3 -(CH 2 ) m -(CHR 1 ) n -(CH 2 ) o COO-R 2 (I), in which
- R 1 is a straight-chain or branched, saturated or unsaturated C 1 -C 8 -alkyl group, m is a number from 3 to 11, n is a number from 1 to 3, o is a number from 0 to 5 and
- R 2 can represent a straight-chain or branched, saturated or unsaturated C 1 -C 24 -alkyl group containing one or more -OC(O)-, -NHC(O)- or -C(OH)- groups in the chain can.
- Esters a) of the formula (I) which are obtainable from crosslinked C 5 -C 8 carboxylic acids and C 12 -C 24 monoalcohols are particularly preferred.
- esters a) of the formula (I) in which
- R 1 is a straight-chain C 1 -C 4 -alkyl radical, very particularly preferably a methyl or ethyl radical, m is a number from 3 to 6, n is the number 1, o is 0 and
- R 2 represents a straight-chain saturated C 1 -C 18 alkyl group.
- Esters a) of 2-ethylhexylcarboxylic acid and myristyl, cetyl and/or stearyl alcohol and in particular esters known by the INCI name cetyl ethylhexanoate are even more preferred.
- hair treatment agents according to the invention contain as ester a) at least one ester of a crosslinked C 5 -C 8 carboxylic acid and a C12-C24 monoalcohol.
- esters a) of 2-ethylhexylcarboxylic acid and myristyl, cetyl and/or stearyl alcohol are particularly preferred.
- An ester a) known by the INCI name cetyl ethylhexanoate is particularly preferred.
- the ester or esters a) are present in the oil phase (II) of the hair treatment composition according to the invention - based on the total weight of the oil phase (II) - preferably in amounts of 6 to 20% by weight and particularly preferably 7 to 17.5% by weight. % used.
- Suitable esters b) are preferably selected from emollients which can be mixed well with esters a) and which have good spreading properties. As with the ester(s) a), it is advantageous if ester b) does not leave a greasy or sticky film on the scalp and/or the hair and does not weigh the hair down, especially if used frequently. Carbonic acid esters meet these requirements.
- carbonic acid esters offer the advantage that they work together with esters a) have at least the same conditioning benefits as analogous products based on silicone and/or mineral oil.
- carbonic acid esters are usually accessible from natural sources, so that the products according to the invention can be used to provide hair care products that are suitable for the so-called clean beauty market.
- Particularly suitable are symmetrical carbonic acid diesters of carbonic acid and at least one C 3 -C 24 alcohol, more preferably a C 4 -C 20 alcohol, particularly preferably a C 5 -C 16 alcohol and very particularly preferably caprylyl, caprylic and/or or lauryl alcohol.
- Carbonic acid esters known under the INCI name dicaprylyl carbonate are particularly preferred esters b). Such products are commercially available, for example, under the name Cetiol® CC from BASF.
- hair treatment agents according to the invention contain at least one symmetrical carbonic acid diester of carbonic acid and at least one C 3 -C 24 alcohol as ester b).
- esters b) of carbonic acid and caprylyl, caprylic and/or lauryl alcohol are particularly preferred.
- An ester b) known by the INCI name Dicaprylyl Carbonate is particularly preferred.
- the ester(s) b) are preferably used in amounts of 70 to 90% by weight and more preferably 75 to 90% by weight in the oil phase (II) of the hair treatment composition according to the invention, based on the total weight of the oil phase (II). .
- hair treatment agents according to the invention it can be advantageous if further active ingredients are added to them.
- hair treatment agents according to the invention preferably contain further active ingredients such as c) solubilizers and/or d) cationic surfactants.
- Suitable solubilizers c) are preferably understood as meaning active ingredients which have skin and/or hair care and solubilizing properties. At the same time, they must not adversely affect the functionality and/or appearance of the products according to the invention.
- Alkoxylated mono- and/or diglycerides have proven to be particularly suitable component(s) c) for use in the hair treatment compositions according to the invention.
- Low ethoxylated mono- and/or diglycerides with a degree of ethoxylation of 5 to 20 are very particularly preferred.
- Such products have moisturizing properties and are able to effectively solubilize and stabilize perfume oil components optionally contained in the hair care products, so that - especially at rest - no undesirable formation of streaks and/or clouding of phases (I) and/or (II) or at the phase boundary occurs.
- suitable components c) support the formation of an emulsion when the hair treatment composition is shaken.
- component(s) c) known under the INCI name PEG-7 Glyceryl Cocoate.
- Such products are commercially available, for example, under the name Cetiol® HE from BASF.
- hair treatment compositions according to the invention contain at least one additional component c), selected from alkoxylated mono- and/or diglycerides, in a proportion by weight of 0.1 to 5% by weight of the total weight of the hair treatment composition.
- 5- to 20-fold ethoxylated mono- and/or diglycerides of glycerol and C 6 -C 24 carboxylic acids are particularly preferred component(s) c).
- a component c) known under the INCI name PEG-7 Glyceryl Cocoate is particularly preferred.
- Component(s) c) preferably alkoxylated mono- and/or diglycerides and in particular 5- to 20-tuply ethoxylated mono- and/or diglycerides of glycerol and C 6 -C 24 -carboxylic acids can (can) be particularly preferred in the hair treatment compositions according to the invention in a proportion by weight of 0.3 to 3% by weight and in particular from 0.5 to 2.5% by weight, based on the total weight of the hair treatment composition.
- Suitable cationic surfactants d) for use in the hair treatment compositions according to the invention preferably have a high hair care potential, a low tendency to foam and the lowest possible emulsifying power.
- Particularly suitable cationic surfactants d) for use in the hair treatment compositions according to the invention are linear or branched, saturated or unsaturated, physiologically tolerable C 1 -C 24 -alkyltri(C 1 -C 4 )alkylammonium salts, di-C 1 -C 24 -alkyldi( C1-C4 ) -alkylammonium salts or tri-C1-C24-alkyl(C1- C4 ) -alkylammonium salts, for example halide and/or methosulfate salts, in particular chlorides, bromides and methosulfates, such as distearyldimethylammonium chloride, lauryltrimethylammonium chloride,
- cetyl trimethyl ammonium chloride cetyl trimethyl ammonium bromide, cetyl trimethyl ammonium methosulfate, stearyl trimethyl ammonium chloride, behenyl trimethyl ammonium chloride, behenyl trimethyl ammonium bromide and behenyl trimethyl ammonium methosulfate.
- cetyltrimethylammonium and behenyltrimethylammonium salts which contain a methosulfate and/or a chloride ion as the anion.
- Such products are commercially available, for example, under the names Dehyquart® A CA from BASF or Genamin® KDMP from Clariant.
- the cationic surfactant(s) d) can be used in the hair treatment compositions according to the invention, preferably in a proportion by weight of 0.01 to 2% by weight, based on the total weight of the hair treatment composition. Amounts used are preferably from 0.05 to 1.5% by weight and in particular from 0.1 to 1% by weight.
- hair treatment compositions according to the invention contain at least one cationic surfactant d) in a proportion by weight of 0.01 to 2% by weight, based on the total weight of the hair treatment composition.
- hair treatment agents which contain at least one linear or branched, saturated or unsaturated, physiologically tolerable C 1 -C 24 -alkyltri(C 1 -C 4 )alkylammonium salt, di-C 1 -C 24 -alkyldi(C 1 -C C 4 )-alkylammonium salt or tri-C 1 -C 24 -alkyl(C 1 -C 4 )-alkylammonium salt.
- hair treatment agents according to the invention contain at least one component c) and at least one component d), preferably 5- to 20-fold ethoxylated mono- and/or diglycerides of glycerol and C 6 -C 24 -carboxylic acids c) and C 1 - C 24 - alkyltri(C 1 -C 4 )-alkylammonium- , di-C 1 -C 24 -alkyldi(C 1 -C 4 )-alkylammonium- and/or tri-C 1 -C 24 - alkyl(C 1 - C 4 )-alkylammonium salts d).
- hair treatment compositions according to the invention can additionally contain a cationic polymer in a proportion by weight of 0.01 to 1% by weight of the total weight of the hair treatment composition to further increase the hair care properties.
- Suitable cationic polymers for use in the hair treatment compositions according to the invention are preferably understood as meaning cationic polymers which are known by the I NCI name “polyquaternium”.
- Particularly suitable cationic polymers are polyquaternium-6, polyquaternium-7, polyquaternium-10, polyquaternium-11, polyquaternium-16, polyquaternium-22, polyquaternium-24, polyquaternium-28, polyquaternium-37, polyquaternium-67, polyquaternium-74 and /or Polyquaternium-89.
- Cationic polymers derived from polymers of natural origin such as cellulose, starch or guar polymers are particularly suitable.
- Cationic cellulose derivatives are offered, for example, by the company Amerchol under the name Polymer JR® and cationic guar polymers by the company Rhone-Poulenc or Hercules under the names Jaguar® or N-Hance®.
- cationic polymers of natural origin are, for example, cationic chitosans, which are commercially available, for example, under the names “Kytamer” or “Hydagen”.
- Quaternium such as Quaternium-8, Quaternium-14, Quaternium-15, Quaternium-18, Quaternium-22, Quaternium-24, Quaternium-26, Quaternium-27, Quaternium- 30, Quaternium-33, Quaternium-53, Quaternium-60, Quaternium-61, Quaternium-72, Quaternium-78, Quaternium-80, Quaternium-81, Quaternium-82, Quaternium-83 and/or Quaternium-84.
- Suitable cationic polymers are, for example - cationic alkyl polyglycosides, - cationized honey, for example the commercial product Honeyquat® 50, - vinylpyrrolidone-vinylimidazolium methochloride copolymers, such as those offered under the names Luviquat® FC 370, FC 550, FC 905 and HM 552, - quaternized polyvinyl alcohol, - as well as the polymers known under the names polyquaternium-2, polyquaternium-17, polyquaternium-18 and polyquaternium-27 with quaternary nitrogen atoms in the polymer main chain,- vinylpyrrolidone-vinylcaprolactam-acrylate terpolymers, such as those with acrylic acid esters and acrylic acid amides as third Monomer building blocks are commercially available, for example, under the name Aquaflex® SF 40.
- Cationic polymers selected from guar hydroxypropyltrimonium chloride, polyquaternium-10, polyquaternium-11, polyquaternium-16, polyquaternium-37, polyquaternium-67, polyquaternium-74 and/or polyquaternium-89 are particularly preferably used in the hair treatment compositions according to the invention.
- they can be advantageous if they contain other active ingredients as long as these do not adversely affect either the stability or the care effect of the two-phase products.
- the other care ingredients can be contained in the water phase (I) or in the oil phase (II).
- the agents according to the invention only include care ingredients that are readily soluble in either the water phase (I) or in the oil phase (II) and/or which do not increase the viscosity of phases (I) and/or (II) too much and thereby making it difficult for them to mix and/or separate.
- Suitable further (care) active ingredients that can be added to the hair treatment agents according to the invention in a proportion by weight of up to 2% by weight of the total weight of the hair treatment agent are i) protein hydrolyzates and/or ii) vegetable oils and/or iii) amino acids and/or their physiologically tolerable salts and/or iv) vitamins.
- hair treatment agents according to the invention contain at least one other hair-conditioning active ingredient selected from i) protein hydrolyzates and/or ii) vegetable oils and/or iii) amino acids and/or their physiologically tolerable salts and/or iv) vitamins, the proportion by weight of one or more components i) to iv) in the total weight of the hair treatment composition is up to 2% by weight.
- Suitable protein hydrolyzates (PH) for use in the hair treatment agents according to the invention are taken to mean both PH of plant and animal, marine or synthetic origin.
- Preferred animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein hydrolysates, which can also be present in the form of salts.
- Such products are sold, for example, under the trademarks Dehylan® (Cognis), Promois® (Interorgana), Collapuron® (Cognis), Nutrilan® (Cognis), Gelita-Sol® (Deutsche Gelatine Fabriken Stoess & Co), Lexein® (Inolex) and Kerasol® (Croda).
- Preferred vegetable protein hydrolysates are, for example, soya, almond, pea, potato and wheat protein hydrolysates. Such products are available, for example, under the trademarks Gluadin® (Cognis), DiaMin® (Diamalt), Lexein® (Inolex), Hydrosoy® (Croda), Hydrolupin® (Croda), Hydrosesame® (Croda), Hydrotritium® (Croda) and Crotein ® (Croda) available.
- Suitable protein hydrolysates of maritime origin include, for example, collagen hydrolysates from fish or algae and protein hydrolysates from mussels or pearl hydrolysates. Examples of pearl hydrolyzates suitable according to the invention are the commercial products Pearl Protein Extract BG® or Crodarom® Pearl.
- Suitable cationized protein hydrolyzates can also be of animal, plant or marine origin.
- the protein hydrolysates or the amino acids can be quaternized with quaternary ammonium salts such as, for example, N,N-dimethyl-N-(n-alkyl)-N-(2-hydroxy-3-chloro-n-propyl)-ammonium halides.
- quaternary ammonium salts such as, for example, N,N-dimethyl-N-(n-alkyl)-N-(2-hydroxy-3-chloro-n-propyl)-ammonium halides.
- the cationic protein hydrolyzates can also be further derivatized.
- Typical examples of particularly suitable cationic protein hydrolyzates and/or derivatives thereof are the products known and commercially available under the INCI names: Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimopnium Hydroxypropyl Hydrolyzed Casein, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Hair Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Rice Protein, Cocodimonium Hydroxypropyl Hydrolyzed Silk, Cocodimonium Hydroxypropyl Hydrolyzed Soy Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Cocodimonium Hydroxypropyl Silk Amino Acids, Hydroxypropyl Arginine Lauryl/Myristyl Ether HCl, Hydroxypropyltrimonium Gelatin, Hydroxypropyltrimonium Hydrolyze
- Keratin, silk, milk protein, wheat and/or soy protein hydrolysates that are quaternized are particularly preferred for use in the hair treatment agents according to the invention be able. Keratin and/or wheat and/or silk protein hydrolysates, which can be quaternized, are particularly preferred.
- the - optionally quaternized - protein hydrolyzates can be used both individually and as a mixture in the hair treatment compositions according to the invention.
- the hair treatment agents contain at least one protein hydrolyzate of animal or vegetable origin and at least one quaternized protein hydrolyzate of animal or vegetable origin.
- the protein hydrolyzates and/or quaternized protein hydrolyzates can be present in the hair treatment agents according to the invention - based on their total weight - preferably in amounts of 0.001 to 2% by weight, preferably 0.0025 to 2% by weight and in particular in amounts of 0.005 to 1% by weight % are used.
- suitable vegetable oils ii) are amaranth seed oil, apricot kernel oil, argan oil, avocado oil, babassu oil, cotton seed oil, borage seed oil, camelina oil, safflower oil, peanut oil, pomegranate seed oil, grapefruit seed oil, hemp oil, rosehip seed oil, hazelnut oil, elder seed oil, currant seed oil, jojoba oil, cocoa butter, Linseed oil, macadamia nut oil, corn oil, almond oil, marula oil, evening primrose oil, olive oil, palm oil, peach kernel oil, rapeseed oil, rice oil, sea buckthorn pulp oil, sea buckthorn kernel oil, sesame oil, shea butter, soybean oil, sunflower oil, grape seed oil, walnut oil and/or wild rose oil.
- Very particularly suitable vegetable oils have a high proportion of triglycerides from unsaturated fatty acids such as oleic acid and in particular palmitoleic acid, such as avocado oil, sea buckthorn pulp oil and/or macadamia nut oil.
- the vegetable oil(s) ii) can be present in the hair treatment compositions according to the invention, preferably in a proportion by weight of in each case 0.01 to 2% by weight (more preferably 0.025 to 1.5% by weight, particularly preferably 0. 05 to 1% by weight and in particular 0.075 to 0.75% by weight) based on the total weight of the hair treatment composition.
- Suitable amino acids iii) can be selected from glycine, alanine, valine, leucine, isoleucine, phenylalanine, tyrosine, taurine, tryptophan, proline, aspartic acid, glutamic acid, asparagine, glutamine, serine, threonine, cysteine, methionine, lysine, arginine, histidine, ß-alanine, 4-aminobutyric acid (GABA), betaine, L-cystine (L-Cyss), L-citrulline, L-theanine, 3',4
- Dihydroxy-L-phenylalanine (L-Dopa), 5'-hydroxy-L-tryptophan, L-homocysteine, S-methyl-L-methionine, S-allyl-L-cysteine sulfoxide (L-alliin), L-frans -4-Hydroxyproline, L-5-Oxoproline (L- pyroglutamic acid), L-phosphoserine, creatine, 3-methyl-L-histidine, L-ornithine and/or the physiologically tolerable salts of these amino acids, it being possible to use both the individual amino acids (or their salts) and mixtures.
- the amino acid(s) or their salt(s) ii) can preferably be present in the hair treatment compositions according to the invention in a proportion by weight of in each case 0.01 to 2% by weight (more preferably 0.025 to 1.5% by weight, particularly preferably 0.05 to 1% by weight and in particular 0.075 to 0.75% by weight) based on the total weight of the hair treatment composition.
- Suitable vitamins which are suitable for use in the hair treatment compositions according to the invention are vitamins, provitamins and vitamin precursors and their derivatives from groups A, B, C, E, F and H.
- vitamin A includes retinol (vitamin Ai) and 3,4-didehydroretinol (vitamin Az).
- ß-carotene is the provitamin of retinol.
- possible vitamin A components are vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as palmitate and acetate.
- the hair treatment compositions can preferably contain the vitamin A component in amounts of 0.005-1% by weight, based on the composition as a whole.
- the vitamin B group or the vitamin B complex include u.
- nicotinic acid and nicotinamide are often referred to under this name.
- Vitamin Bs pantothenic acid, panthenol and pantolactone.
- panthenol and/or pantolactone preference is given to using panthenol and/or pantolactone.
- Derivatives of panthenol that can be used are, in particular, the esters and ethers of panthenol and cationically derivatized panthenols.
- Individual representatives are, for example, panthenol triacetate, panthenol monoethyl ether and its monoacetate, and cationic panthenol derivatives.
- the compounds of the vitamin Bs type mentioned can preferably be present in the hair treatment compositions in amounts of 0.05-5% by weight, based on the composition as a whole. Amounts of 0.1-2% by weight are particularly preferred
- Vitamin Be pyridoxine as well as pyridoxamine and pyridoxal
- Vitamin C (ascorbic acid). Vitamin C can preferably be used in the hair treatment compositions in amounts of 0.01 to 3% by weight, based on the composition as a whole. Use in the form of the palmitic acid ester, the glucoside or phosphate may be preferred. Use in combination with tocopherols may also be preferred.
- Vitamin E tocopherols, especially a-tocopherol.
- Tocopherol and its derivatives including in particular the esters such as acetate, nicotinate, phosphate and succinate, can be contained in the hair treatment compositions in amounts of 0.005-1% by weight, based on the composition as a whole.
- Vitamin F usually means essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.
- Vitamin H The compound (3aS,4S,6aR)-2-oxohexahydrothienol[3,4-d]imidazole-4-valeric acid is known as vitamin H, for which the trivial name biotin has meanwhile prevailed.
- Biotin can preferably be contained in the hair treatment compositions in amounts of 0.0001 to 1.0% by weight, in particular in amounts of 0.001 to 0.01% by weight.
- the hair treatment agents according to the invention can particularly preferably contain vitamins, provitamins and vitamin precursors from groups A, B, E and H. Panthenol, pantolactone, pyridoxine and its derivatives as well as nicotinamide and biotin are particularly preferred and can be added to the hair conditioners according to the invention either individually or in combination in the amounts mentioned above.
- the hair treatment compositions according to the invention can contain active ingredients for pH regulation, preferably acids such as, in particular, acetic acid, citric acid, malic acid, maleic acid, formic acid, amidosulfonic acid, phosphoric acid, phosphonic acids, D-lactic acid, L-lactic acid, D/L-lactic acid, Oxalic acid or from the group of alkalis, such as in particular caustic soda.
- acids such as, in particular, acetic acid, citric acid, malic acid, maleic acid, formic acid, amidosulfonic acid, phosphoric acid, phosphonic acids, D-lactic acid, L-lactic acid, D/L-lactic acid, Oxalic acid or from the group of alkalis, such as in particular caustic soda.
- Hair treatment agents according to the invention advantageously contain active ingredients for pH regulation in amounts of 0.01-5% by weight, preferably 0.01-3% by weight and in particular 0.01-2% by weight (based on the total weight of the hair treatment agent).
- lactic acid should be mentioned in particular, because lactic acid can help to regulate skin moisture on the scalp and contribute to color protection in colored hair. It has been found that it is advantageous for particularly good stability of the two phases (I) and (II) of the hair treatment composition according to the invention if they only contain specific surfactants and/or emulsifiers in specific amounts.
- Stability means that the two phases quickly separate again after mixing and form a sharp horizontal phase boundary at which, ideally, no turbidity occurs over a long period of time and with temperature fluctuations.
- Surfactants and/or emulsifiers which favor too much the emulsification and/or suspension of the oil phase in the water phase or vice versa are therefore not suitable for use in the compositions according to the invention.
- Foam formation when the hair treatment composition according to the invention is shaken immediately before use is also undesirable, which is why surfactants/emulsifiers that tend to form large amounts of foam are also excluded.
- hair treatment agents according to the invention contain a maximum of 1% by weight, more preferably a maximum of 0.8% by weight, particularly preferably a maximum of 0.6% by weight and in particular a maximum of 0.5% by weight, of anionic, amphoteric, zwitterionic and/or nonionic surfactants (based on the total weight of the hair treatment composition).
- the hair treatment compositions according to the invention contain no further anionic, amphoteric, zwitterionic and/or nonionic surfactants.
- Hair treatment agents according to the invention which, in addition to the essential and optional ingredients already described, contain a maximum of 0.5% by weight, particularly preferably a maximum of 0.3% by weight and in particular a maximum of 0.1% by weight in their oil phase (II) are therefore particularly advantageous. -% of other oil and/or fat substances included (based on the oil phase (II)).
- the hair treatment agents according to the invention contain no further oil and/or fatty substances, in particular no fatty alcohols, in addition to the components of the oil phase (II) described earlier in this application.
- hair treatment agents according to the invention are essentially free from fatty alcohols.
- Essentially free is understood to mean that the hair treatment compositions according to the invention—based on their total weight—contain a maximum of 0.05% by weight, particularly preferably a maximum of 0.01% by weight and in particular 0% by weight of fatty alcohols. As already stated earlier in this application, it is not necessary for the care effect and the stability of the hair treatment compositions according to the invention to add further components (oil and fat substances) to the oil phase.
- both silicones and mineral oils can be dispensed with.
- Perfume oils are not included in the aforementioned oily and fatty substances in this context. These can preferably be present in the oil phase in an amount of 0.1 to 1% by weight, more preferably 0.15 to 0.9% by weight, particularly preferably 0.2 to 0.8% by weight and in particular 0 .25 to 0.75% by weight (based on the total weight of the oil phase) can be used.
- hair treatment agents according to the invention can contain other active substances, auxiliaries and additives, such as, for example
- Anti-dandruff active ingredients such as Piroctone Olamine, Zinc Omadine and Climbazole
- Penetration aids and/or swelling agents such as urea, hydantoin and/or their derivatives.
- the hair conditioners according to the invention preferably have a pH in the range from 2 to 7, preferably from 2.5 to 6 and in particular from 3 to 4.
- the two-phase hair treatment agents according to the invention have the advantage that they are easy to use and simple to produce.
- the special combination of active ingredients in the hair treatment products ensures rapid mixing of the two phases before application and rapid separation of the two phases after application.
- the hydrophilic phase is predominantly water based, which meets consumer needs.
- the hair treatment agents according to the invention are also particularly suitable for hair care.
- the presence of (cyclic) silicones and/or mineral oils is neither for the stability nor for the care properties of the hair treatment preparations are necessary because the hair treatment preparations according to the invention have comparably good conditioning advantages on hair treated therewith compared to preparations containing silicones and/or mineral oils.
- the hair treatment compositions according to the invention can be sprayed and are suitable for application from a pump dispenser. This makes them easy to use and effective in their effect, because the fine spray mist emerging from the pump dispenser reaches all areas of the hair.
- a second subject of the invention is a method for conditioning hair, in which a hair treatment composition according to the invention is applied (preferably sprayed) to wet or dry hair after vigorous shaking and left on the hair until the next hair cleaning.
- a third subject matter of the invention is the use of the hair treatment agent according to the invention to improve hair care, in particular to improve combability, hair shine and hair feel.
- compositions (I) and (II) according to the invention and a comparative composition (III) were prepared.
- compositions (II) and (III) were evaluated by subjects with regard to a number of product and care properties (consistency of the product; spreadability; smell; manageability of wet hair; combability of wet and dry hair; hair feel of wet and dry hair; Formability / manageability; Feel of the hair tips; Static charge; Shine; Bounce; Fullness of the hair; Degree of care; Softness of the hair; Suppleness of the hair).
- the two products were neutrally packaged and coded, used in equal quantities on three models in a half-side test and assessed by an expert.
- the straight, untreated hair of Models 1 and 2 had normal (healthy) hair and scalp condition and medium density and hair diameter.
- the bleached hair of Model 3 was porous, of lower density and hair diameter. Grades from 1 to 6 could be awarded, with grade 1 being bad and grade 6 being very good.
- composition (II) according to the invention was rated approximately the same as the composition (III) in almost all of the aforementioned categories.
- composition (II) according to the invention was rated better than the comparative composition (III) containing mineral oils (overall rating (II)—average value: 4.75; Overall rating (III) - average value: 4.65).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
L'invention concerne des produits de traitement capillaire se présentant sous la forme d'un système à deux phases comprenant deux phases continues distinctes, reconnaissables visuellement et présentant une limite de phase horizontale commune, contenant une phase aqueuse (I) et une phase huileuse (II), la phase huileuse (II) contenant par rapport à son poids total un mélange de a) 5 à 25 % en poids d'au moins un monoester et/ou diester d'un acide carboxylique en C4-C12 ramifié et d'un monoalcool ou dialcool en C4-C12 linéaire ou ramifié, saturé ou insaturé, et b) 65 à 90 % en poids d'au moins un ester d'acide carbonique. Les produits de traitement selon l'invention conviennent pour l'amélioration des soins capillaires, en particulier pour l'amélioration de la coiffabilité, de la brillance des cheveux et du toucher des cheveux.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102020211880.9A DE102020211880A1 (de) | 2020-09-23 | 2020-09-23 | Zweiphasen-Pflegespray für Haare |
PCT/EP2021/073951 WO2022063528A1 (fr) | 2020-09-23 | 2021-08-31 | Spray de soins à deux phases pour les cheveux |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4216914A1 true EP4216914A1 (fr) | 2023-08-02 |
Family
ID=77801698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21772738.7A Pending EP4216914A1 (fr) | 2020-09-23 | 2021-08-31 | Spray de soins à deux phases pour les cheveux |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP4216914A1 (fr) |
DE (1) | DE102020211880A1 (fr) |
WO (1) | WO2022063528A1 (fr) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2939662B1 (fr) | 2008-12-17 | 2011-02-11 | Oreal | Composition biphase transparente sans silicones |
DE102018221949A1 (de) | 2018-12-17 | 2020-06-18 | Henkel Ag & Co. Kgaa | Silikon-freie Zweiphasen-Haarkur |
-
2020
- 2020-09-23 DE DE102020211880.9A patent/DE102020211880A1/de active Pending
-
2021
- 2021-08-31 EP EP21772738.7A patent/EP4216914A1/fr active Pending
- 2021-08-31 WO PCT/EP2021/073951 patent/WO2022063528A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
WO2022063528A1 (fr) | 2022-03-31 |
DE102020211880A1 (de) | 2022-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3185847B1 (fr) | Procédé pour augmenter la résistance au lavage des cheveux artificiellement colorés | |
DE102015223828A1 (de) | Leistungsstarke Haarbehandlungsmittel mit Anti-Auswasch-Effekt | |
DE102008035172A1 (de) | Strukturierte Zusammensetzung mit optimalen Lager-Stabilitäts-Eigenschaften | |
EP1143922A2 (fr) | Agent a deux phases, contenant du parfum, pour le soin des cheveux ou de la peau | |
WO2020126219A1 (fr) | Soin capillaire à deux phases exempt de silicone | |
DE102018215749A1 (de) | Haarpflegemittel mit speziellen nachwachsenden Rohstoffen | |
DE102016219005A1 (de) | Verbessert konditionierende Haarbehandlungsmittel mit Auswaschschutz | |
DE19809942A1 (de) | Dosierbares kosmetisches Pflegemittel | |
EP4216914A1 (fr) | Spray de soins à deux phases pour les cheveux | |
EP2444056A1 (fr) | Agents de conditionnement capillaire en deux phases pulvérisables | |
WO2022042979A1 (fr) | Agents de traitement capillaire ayant des effets antipelliculaires | |
WO2013083349A1 (fr) | Produits de soins capillaires | |
WO2020207643A1 (fr) | Shampoing à rinçage rapide | |
EP3337570B1 (fr) | Shampooing de conditionnement avec mélange d'ester d'huiles végétales | |
DE102021214298A1 (de) | Zweiphasen-Pflegespray für Haare | |
DE102013212623A1 (de) | Haarbehandlungsmittel enthaltend das Öl aus der Frucht des Feigenkaktus | |
DE102016218999A1 (de) | Verbessert konditionierende Haarbehandlungsmittel mit Auswaschschutz | |
DE102016219006A1 (de) | verbessert konditionierende Haarbehandlungsmittel mit Auswaschschutz | |
DE102015223855A1 (de) | Leistungsstarke Haarbehandlungsmittel mit Anti-Auswasch-Effekt | |
WO2023193967A1 (fr) | Produits de soins capillaires à action antipelliculaire | |
DE102022202187A1 (de) | "2-Phasen-Silicon-Spray-Conditioner" | |
DE102013212621A1 (de) | Haarbehandlungsmittel enthaltend Blütennektar | |
DE102013212618A1 (de) | Haarbehandlungsmittel enthaltend Pequi-öl | |
DE102013223918A1 (de) | Haarbehanslungsmittel enthaltend Rosa Damascena Flower Oil | |
DE102010062299A1 (de) | Haarbehandlungsmittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20230116 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) |